fda glp-1 shortage list lawsuit The Wins. The OFA Loses. And Semaglutide Is Off the for Good US judge sides with FDA's
Description
He notes that in humans GLP-1 reduces pancreatic inflammation and rarely increases amylase and lipase to more than the 3- fold increase which is needed to meet diagnostic criteria for pancreatitis
As of January 2026, Wegovy is also available as a daily oral tablet
If the cases proceed, Judge Marston is expected to schedule bellwether trials to help evaluate how juries respond to the evidence
Lilly is expanding the category itself, drawing in new patients in addition to market share gains from injectable rivals
Recently, scientists have explored its potential to slow aging and extend healthy lifespan
Monocarboxylate transporters in the central nervous system: distribution, regulation and function
